Summary & Overview
HCPCS M1221: Dilated Retinal Exam with Interpretation, No Retinopathy
HCPCS Level II code M1221 represents a dilated retinal eye examination with professional interpretation (including documented and reviewed artificial intelligence interpretation) that documents no evidence of retinopathy. This code captures a common ophthalmic surveillance encounter used for screening and routine monitoring of retinal health when diabetic or other retinopathy is not present. Nationally, clear coding supports appropriate clinical documentation, facilitates population-level surveillance, and affects billing pathways where AI-assisted interpretations are used.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for M1221, how the service is typically delivered in outpatient ophthalmology or optometry settings, and which payers commonly cover this encounter type. The publication also outlines benchmarks and coding guidance relevant to billing and reimbursement workflows, highlights policy updates concerning use of documented AI interpretations, and situates the code within common service-lines for eye care.
This summary is intended for clinicians, coding professionals, and healthcare administrators seeking an authoritative, national-level briefing on the purpose and implications of HCPCS Level II code M1221.
Billing Code Overview
HCPCS Level II code M1221 describes a dilated retinal eye exam with interpretation performed by an ophthalmologist, optometrist, or an artificial intelligence (ai) interpretation that is documented and reviewed, without evidence of retinopathy.
Service Type: Dilated retinal eye examination with professional interpretation
Typical Site of Service: Ophthalmology or optometry clinic, outpatient eye care setting, or other ambulatory care setting where retinal examinations are performed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 56-year-old patient with type 2 diabetes presents for an annual dilated retinal examination. The patient is seen in an ophthalmology clinic; dilation drops are instilled, and a full dilated fundus exam is performed by an optometrist or ophthalmologist. Findings are documented as no diabetic retinopathy or other retinal pathology. The examination may be performed with in-person interpretation by a credentialed eye care provider or with an approved artificial intelligence (AI) platform interpretation that is documented and reviewed by the ophthalmologist or optometrist. The clinical workflow includes patient check-in, vision and intraocular pressure screening as indicated, pharmacologic dilation, timed fundus examination with direct/indirect ophthalmoscopy or fundus photography, interpretation (clinician or AI), documentation of results, counseling, and scheduling of follow-up (routine annual or sooner if changes occur). Typical site of service is an ophthalmology or optometry clinic within an outpatient office or ambulatory surgical center setting.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the dilated exam requires significantly greater work than typical and documentation supports additional work. |